Public sector financial support for late stage discovery of new drugs in the United States: cohort study.
Rahul K NayakJerry AvornAaron S KesselheimPublished in: BMJ (Clinical research ed.) (2019)
A review of the patents associated with new drugs approved over the past decade indicates that publicly supported research had a major role in the late stage development of at least one in four new drugs, either through direct funding of late stage research or through spin-off companies created from public sector research institutions. These findings could have implications for policy makers in determining fair prices and revenue flows for these products.